Skip to main content
# Title Department Research Member Research Year
131 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ayat allah Ali yousseif 2021
132 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
133 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Duaa Abdel-Samia Mohamed Ali 2021
134 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
135 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2021
136 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Department of Radiology Marwa Ali Mohammed Abdel fattah 2021
137 Validation of imaging reporting and data system of coronavirus disease 2019 lexicons CO-RADS and COVID-RADS with radiologists’ preference: a multicentric study Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2021
138 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
139 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
140 Two-be SPECT/CT versus planar bone scintigraphy: Prospective comparison of reproducibility and diagnostic performance Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021